In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species

被引:25
作者
Karlowsky, JA
Harding, GAJ
Zelenitsky, SA
Hoban, DJ
Kabani, A
Balko, TV
Turik, M
Zhanel, GG
机构
[1] HLTH SCI CTR,DEPT CLIN MICROBIOL,WINNIPEG,MB R3A 1R9,CANADA
[2] HLTH SCI CTR,DEPT MED,WINNIPEG,MB R3A 1R9,CANADA
[3] UNIV MANITOBA,FAC PHARM,WINNIPEG,MB R3T 2N2,CANADA
[4] UNIV MANITOBA,FAC MED,DEPT MED MICROBIOL,WINNIPEG,MB R3T 2N2,CANADA
[5] LILLY RES LABS,INDIANAPOLIS,IN
关键词
D O I
10.1128/AAC.41.11.2576
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In vitro killing by a new semisynthetic echinocandin, LY-303366, was characterized using clinical isolates of fluconazole-sensitive (Y58) and -resistant (Y180) Candida albicans as well as Candida glabrata (Y7) and Candida krusei (Y171). The 24-h kill curves for Y58 and Y180 demonstrated dose-independent killing of between 1 and 2 log(10) with LY-303366 at concentrations of 0.1, 1, 10, 50, 100, and 1,000 times the MIC. Regrowth did not occur at 24 h with either C. albicans isolate at the aforementioned LY-303366 concentrations. At their MICs, LY-303366 and amphotericin B produced similar killing kinetics in cultures of Y58, Y180, Y7, and Y171, while all cultures exposed to fluconazole at its MIC demonstrated stasis or growth over 24 h.
引用
收藏
页码:2576 / 2578
页数:3
相关论文
共 14 条
[1]   SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989 [J].
BANERJEE, SN ;
EMORI, TG ;
CULVER, DH ;
GAYNES, RP ;
JARVIS, WR ;
HORAN, T ;
EDWARDS, JR ;
TOLSON, J ;
HENDERSON, T ;
MARTONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S89
[2]  
CURRENT WL, 1993, 33 INT C ANT AG CHEM, P186
[3]  
DEBONO M, 1994, EXPERT OPIN INV DRUG, V3, P821
[4]   Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp. [J].
Ernst, ME ;
Klepser, ME ;
Wolfe, EJ ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (3-4) :125-131
[5]  
Gooday G. W., 1995, EXPERT OPIN INV DRUG, V4, P679
[6]  
*NAT COMM CLIN LAB, 1995, M27T NAT COMM CLIN L
[7]   IMPACT OF THE CHANGING EPIDEMIOLOGY OF FUNGAL-INFECTIONS IN THE 1990S [J].
PFALLER, M ;
WENZEL, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (04) :287-291
[8]  
PFALLER MA, 1996, 36 INT C ANT AG CHEM, P108
[9]  
RENNIE R, 1996, 36 INT C ANT AG CHEM, P107
[10]  
STEVENS DA, 1996, 36 INT C ANT AG CHEM, P107